Key factors influencing vomiting risk include: Dose escalation speed rapid increases in dose are associated with higher symptom rates Individual susceptibility some patients are inherently more prone to gastrointestinal side effects Concurrent medications other drugs affecting gastric motility may compound effects Dietary habits large, high-fat meals can exacerbate symptoms It is important to note that whilst mild, occasional vomiting can be an expected side effect, severe or persistent vomiting is not normal and may indicate complications requiring medical assessment
Back Gilbert, B, Rosenthal, D (5 March 2024) 'The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)', Acquired podcast, ACQ2 Episode
If that is what you need, it delivers well
Beyond the Prescription: This is a Holistic Journey A GLP-1 medication is an incredibly powerful tool
Slows Stomach Emptying Food stays longer in the stomach, reducing appetite
Monarch Medicine is not affiliated with or endorsed by Novo Nordisk or Eli Lilly